Literature DB >> 6429083

Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro.

U P Thorgeirsson, T Turpeenniemi-Hujanen, L M Neckers, D W Johnson, L A Liotta.   

Abstract

The effects of protein and DNA synthesis inhibitors on in vitro tumor cell invasion was studied in a quantitative invasion system using human amnion. Highly invasive M5076 tumor cells were incubated on the basement membrane (BM) of the amnion in the presence of cycloheximide, aphidicolin or sodium butyrate. Tumor cell penetration through the entire thickness of the amnion was measured after 24 h. Protein synthesis in the M5076 cells was inhibited 95% within 1 h by 10(-6)M cycloheximide while DNA synthesis was unaffected. Treatment with cycloheximide reduced the number of spontaneously invading cells by 82% and by 66% in the presence of the chemoattractant, formylmethyl leucine-phenylalanine (FMLP), known to stimulate invasiveness. DNA synthesis in the M5076 tumor cells was selectively inhibited with aphidicolin (10 micrograms/ml). Although the DNA synthesis was greatly reduced, no significant effect on invasiveness with or without FMLP was observed. A less specific inhibitor of DNA synthesis, sodium butyrate (1 mM), arrested cell proliferation in the G1 phase of the cell cycle. When the butyrate-treated M5076 cells were tested in the invasion assay, a 50% increase in the number of invasive cells was observed. All three inhibitors were used in concentrations that did not affect cell viability or cell attachment to the amnion. These data indicate that protein synthesis but not DNA synthesis and not cell proliferation are required for tumor cells to invade native connective tissue barriers in vitro.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429083

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  15 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  Treatment with human recombinant leukocyte interferons inhibits in vitro invasive ability of human lung carcinoma cells.

Authors:  T J Ravine; N Ledinko
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

3.  Confrontation of an invasive (MO4) and a noninvasive (MDCK) cell line with embryonic chick heart fragments in serum-free culture media.

Authors:  M E Bracke; M De Mets; R M Van Cauwenberge; L Vakaet; G K De Bruyne; M M Mareel
Journal:  In Vitro Cell Dev Biol       Date:  1986-09

4.  A model for tumorigenicity and metastatic potential: growth in 1.0% agar cultures.

Authors:  T Saiga; T Ohbayashi; K Tabuchi; O Midorikawa
Journal:  In Vitro Cell Dev Biol       Date:  1987-12

5.  The effect of butyric acid and retinoic acid on invasion and experimental metastasis of murine melanoma cells.

Authors:  T W McGarvey; S Silberman; B Persky
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

Review 6.  Tumor invasion and metastases: role of the basement membrane. Warner-Lambert Parke-Davis Award lecture.

Authors:  L A Liotta
Journal:  Am J Pathol       Date:  1984-12       Impact factor: 4.307

Review 7.  Gene products which play a role in cancer invasion and metastasis.

Authors:  L A Liotta
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

8.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 9.  Mechanisms of tumor invasion: evidence from in vivo observations.

Authors:  H Gabbert
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

10.  Attachment and invasion of high- and low-metastatic clones of RCT sarcoma in a three-dimensional culture system.

Authors:  N Makiyama; H Matsui; H Tsuji; K Ichimura
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.